Home
Conditions
Neoplasms, Germ Cell and Embryonal

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,096 public trials 1,232 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Active, Not Recruiting

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

NCT04802876

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +111 more
Locations: Grupo SOLTI Barcelona, Spain

View Trial Details

Active, Not Recruiting

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

NCT03496402

Conditions: Central Nervous System Neoplasms, Central Nervous System Tumor, Ewing Sarcoma Family of Tumors, +24 more
Locations: Chu D'Amiens Picardie Amiens, France

CHU Angers Angers, France

CHRU de Besançon - Hôpital Jean-Minjoz Besançon, France

CHU de Bordeaux - Hôpital des enfants - Groupe Hospitalier Pellegrin Bordeaux, France

View all 30 locations

View Trial Details

Active, Not Recruiting

Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients

NCT06054529

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: AdventHealth Translational Research Institute Orlando, Florida, United States

View Trial Details

Active, Not Recruiting

Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma

NCT06863870

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Active, Not Recruiting

Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

NCT05736523

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Intermountain Medical Center Murray, Utah, United States

Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Active, Not Recruiting

Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM

NCT03452579

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Active, Not Recruiting

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

NCT05732805

Conditions: Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +16 more
Locations: Healthcare Institution "Bobruisk Interdistrict Oncological Dispensary" Babruysk, Belarus

Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus

Health care institution "Grodno University Clinic" Grodno, Belarus

Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus

View all 63 locations

View Trial Details

Active, Not Recruiting

Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists

NCT03412058

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations: Institut Bergonie Bordeaux, France

Centre Hospitalier de Caen Caen, France

Centre Jean Perrin Clermont-Ferrand, France

Centre Hospitalier Inter. de Creteil Créteil, France

View all 19 locations

View Trial Details

Active, Not Recruiting

Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas

NCT03181477

Conditions: Astrocytoma, Glioblastoma, Glioblastoma, Adult, +8 more
Locations: CHU Amiens Picardie Amiens, France

CHU Besançon Besançon, France

Centre Georges François Leclerc Dijon, France

Centre d'oncologie et de radiothérapie Mâcon, France

View Trial Details

Active, Not Recruiting

AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma

NCT04881032

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: CHU de Brest Brest, France

Centre Jean Perrin Clermont-Ferrand, France

CHU de Grenoble Grenoble, France

Centre Léon Berard Lyon, France

View Trial Details

Neoplasms, Germ Cell and Embryonal

Neoplasms, Germ Cell and Embryonal trial results

Related conditions